source
- ADARx Pharmaceuticals, backed by AbbVie, files for IPO with three RNAi drugs in clinical trialsADARx Pharmaceuticals, an RNA interference biotech based in San Diego, disclosed its plan to go public in a Friday night SEC filing. The company aims to capitalize on the current momentum in biotec…
- STAT readers weigh in on MD vs DO training, AI accountability and surrogacy in medicineSTAT’s First Opinion platform invites letters that respond to its essays, and a recent submission addresses several hot topics in health care. The writer acknowledges the bias that osteopathic gra…